Literature DB >> 32360025

Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study.

Francisco J Blanco1, Maite Silva-Díaz2, Víctor Quevedo Vila3, Daniel Seoane-Mato4, Fernando Pérez Ruiz5, Antonio Juan-Mas6, José M Pego-Reigosa7, Javier Narváez8, Neus Quilis9, Raúl Cortés10, Antonio Romero Pérez11, Dolores Fábregas Canales12, Teresa Font Gayá13, Carolina Bordoy Ferrer13, Carlos Sánchez-Piedra4, Federico Díaz-González14, Sagrario Bustabad-Reyes15.   

Abstract

INTRODUCTION: The Spanish Society of Rheumatology carried out the EPISER2000 study in 2000 to determine the prevalence of osteoarthritis and other rheumatic diseases in the Spanish population. Recent sociodemographic changes and lifestyle habits in Spain justified updating the epidemiological data on osteoarthritis and other rheumatic diseases (EPISER2016-study).
OBJECTIVE: To estimate the prevalence of symptomatic osteoarthritis of the cervical spine, lumbar spine, hip, knee and hand in the adult population in Spain.
MATERIAL AND METHODS: Cross-sectional population-based study. A multistage and stratified random cluster sampling was carried out. The participants were contacted by telephone to complete an osteoarthritis screening questionnaire. A rheumatologist confirmed or discarded the diagnosis. The ACR-clinical-criteria were used to diagnose hand-osteoarthritis and the ACR-clinical-radiological criteria to diagnose knee- and hip-osteoarthritis. To estimate the prevalence and its 95% confidence interval, weights were calculated according to the probability of selection in each of the sampling stages.
RESULTS: The prevalence of osteoarthritis in Spain in one or more of the locations studied was 29.35%. The prevalence of cervical-osteoarthritis was 10.10% and of lumbar-osteoarthritis 15.52%. Both are more frequent in women and at older ages, as well as in people with low levels of education and obesity. The prevalence of hip-osteoarthritis was 5.13%, that of knee-osteoarthritis 13.83%, these are associated with female sex, overweight and obesity. The prevalence of hand osteoarthritis was 7.73%. It is more frequent in women, who are obese, with a low educational level and who are older.
CONCLUSION: The EPISER2016 study is the first to analyse the prevalence of symptomatic osteoarthritis in 5 locations (cervical, lumbar, knee, hip and hands) in Spain. Lumbar spine osteoarthritis is the most prevalent.
Copyright © 2020. Publicado por Elsevier España, S.L.U.

Entities:  

Keywords:  Arthrosis; Artrosis; Artrosis de cadera; Artrosis de manos; Artrosis de rodilla; EPISER2016; Hands osteoarthritis; Hip osteoarthritis; Knee osteoarthritis; Osteoarthritis; Osteoartritis

Year:  2020        PMID: 32360025     DOI: 10.1016/j.reuma.2020.01.008

Source DB:  PubMed          Journal:  Reumatol Clin (Engl Ed)        ISSN: 2173-5743


  4 in total

1.  Point prevalence of Hip Symptoms, Radiographic, And Symptomatic OA at Five Time Points: The Johnston County Osteoarthritis Project, 1991-2018.

Authors:  Amanda E Nelson; David Hu; Liubov Arbeeva; Carolina Alvarez; Rebecca J Cleveland; Todd A Schwartz; Louise B Murphy; Charles G Helmick; Leigh F Callahan; Jordan B Renner; Joanne M Jordan; Yvonne M Golightly
Journal:  Osteoarthr Cartil Open       Date:  2022-03-15

2.  [Impact of lockdown on physical activity of patients with osteoarthritis during the COVID-19 pandemic].

Authors:  J M Román Belmonte; E Muñoz de la Torre; A Vázquez Sasot; M T Sánchez Polo; B A Rodríguez Damiani; C Resino Luís
Journal:  Rehabilitacion (Madr)       Date:  2022-03-07

3.  Future projections of opioid use and cost in patients with chronic osteoarthritis pain in Spain.

Authors:  Javier Rejas-Gutierrez; Antoni Sicras-Mainar; Josep Darbà
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-04-29       Impact factor: 5.346

4.  Sick Leave and Costs in Active Workers with Chronic Osteoarthritis Pain in Spain: Outcomes of the OPIOIDS Real World Study.

Authors:  Antoni Sicras-Mainar; Juan Carlos Tornero-Tornero; Francisco Vargas-Negrín; Isabel Lizarraga; Aram Sicras-Navarro; Javier Rejas-Gutierrez
Journal:  Open Access Rheumatol       Date:  2022-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.